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Abstract
Background/Aim. Infection following total hip arthroplasty
(THA) or total knee arthoplasty (TKA) may have devastating
consequences. Some bacterial strains are often encountered
as agents of these infections, others occur less frequently but
are sometimes burdened with more severe complications.
Klebsiella spp. are uncommon causes of THA or TKA infec-
tion. The aim of this study was to identify an effective treat-
ment algorithm for multidrug resistant Klebsiella spp. caused
THA or TKA infections. Methods. During the 3-year pe-
riod, from January 1 2009 to December 31 2011, we regis-
tered and treated 5 patients with THA or TKA multidrug re-
sistant Klebsiella spp. caused infection. All the patients were
primarily operated in other institutions, and were admitted in
our clinic after the onset of infection symptoms. In three of
the cases Klebsiella infection was complicated by additional in-
fection (Staphyloccocus aureus, Pseudomonas aeruginosa and Serratia
marscescens). In 3 of the cases we performed revision arthro-
plasty after double exchange of antibiotic-loaded articulating
cement spacer, and in 2 of the cases the standard two-stage
revision approach with one antibiotic cement spacer ex-
change was applied. Results. The mean length of follow-up
after reimplantation surgery was 17.1 months (range 2–31
months). One patient died 2 months after the final reimplan-
tation procedure. The initial Klebsiella infection was eradicated
in all the patients. At the end follow-up after definitive reim-
plantation, the patients had no clinical, laboratory or micro-
biological parameters positive for active infection. Conclu-
sion. According to our experience with multidrug-resistant
Klebsiella TKA/THA infections, two-stage approach, in some
cases with double articulating cement spacer exchange prior
to definitive reimplantation, is the most effective treatment
option.
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Apstrakt
Uvod/Cilj. Infekcije totalnih artroplastika kuka (THA) i
totalnih artroplastika kolena (TKA) mogu imati teške po-
sledice. Neke baterije su ÿešýi uzroÿnici, druge se javljaju
reĀe, ali su ponekad te infekcije optereýene težim tokom i
komplikacijama. Klebsiella bakterije su retki uzroÿnici ovih
infekcija. Cilj rada bio je identifikacija efikasnog algoritma
za leÿenje infekcija THA i TKA koje izaziva Klebsiella.
Metode. U 3-godišnjem periodu, od 1. januara 2009. do
31. decembra 2011, registrovali smo i leÿili pet bolesnika
sa THA ili TKA infekcijom uzrokovanom multirezistent-
nim sojem bakterije Klebsiella. Svi bolesnici su primarno
operisani u drugim ustanovama, a u našu kliniku su bili
primljeni posle pojave znakova infekcije. Kod tri bolesni-
ka infekcija bakterijom Klebsiella bila je komplikovana do-
datnom infekcijom (Staphyloccocus aureus, Pseudomonas aeru-
ginosa i Serratia marscescens). Kod tri bolesnika izvedena je
reviziona artroplastika nakon dvostruke izmene antibiot-
skog cementnog spejsera, a kod dva bolesnika reviziona
artroplastika sa jednom izmenom spejsera. Rezultati.
Srednja vrednost perioda praýenja bila je 17,1 mesec (od 2
do 31). Jedan bolesnik preminuo je dva meseca nakon
druge reimplantacione procedure. Klebsiella infekcije izle-
ÿene su kod svih bolesnika. Na kraju perioda praýenja na-
kon definitivne reimplantacija, bolesnici nisu imali kliniÿ-
kih, laboratorijskih, niti mikrobioloških parametara pozi-
tivnih na prisustvo aktivne infekcije. Zakljuÿak. Nakon
našeg iskustva sa TKA/THA infekcijama prouzrokova-
nim multirezistentnim sojevima bakterije Klebsiella ustano-
vili smo da je pristup sa dvostrukom izmenom artikular-
nih cementnih spejsera pre definitivne reimplantacije na-
jefikasnija opcija leÿenja.
Kljuÿne reÿi:
artroplastika kuka; artroplastika kolena; infekcija,
bakterijska; klebsiella; ortopedske procedure;
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Introduction
Infection following total hip arthroplasty (THA) or total
knee arthroplasty (TKA) may have devastating consequences
for the patient. The incidence of infection associated with
THA or TKA in many studies has been reported to range
from less than 1% in general population to almost 4% in pa-
tient groups with comorbidities such as rheumatoid arthritis,
that increase risk of infection 
1–3.
Some bacterial strains are often encountered as agents
of these infections, others occur less frequently but are
sometimes burdened with more severe complications.
Bacteria belonging to the genus Klebsiella frequently
cause human nosocomial infections. Klebsiella spp. are
gram-negative, nonmotile, usually encapsulated rod-shaped
bacteria, belonging to the family Enterobacteriaceae 
4, 5.
These bacteria produce lysine decarboxylase but not ornith-
ine decarboxylase and are generally positive in the Voges-
Proskauer test. Members of the Enterobacteriaceae family
are generally facultatively anaerobic, and range from 0.3 to
1.0 mm in width and 0.6 to 6.0 mm in length 
5. Klebsiella
spp. often occur in mucoid colonies 
4, 5. The principal patho-
genic reservoirs for transmission of Klebsiella are the gas-
trointestinal tract and the hands of hospital personnel. In par-
ticular, Klebsiella pneumonia, the medically most important
Klebsiella species, accounts for a notable proportion of hos-
pital-acquired urinary tract infections, pneumonia, septice-
mias, and soft tissue infections. It is estimated that Klebsiella
spp. cause 8% of all nosocomial bacterial infections in the
United States and in Europe 
6. Fortunately Klebsiella spp. are
not common infective agents in TKA or THA infections,
with a relatively small number of reports on the subject of
Klebsiella periprosthetic infection in the literature 
7, 8.
Two-stage reimplantation with antibiotic loaded cement
spacers and 4–6 weeks of antibiotic treatment remains the
most successful procedure for infection resolution. In most
of the series  success rates are up to 95 % 
9, 10. In cases of
persistent multidrug-resistant (MDR) Klebsiella spp. infec-
tion there is a limited role for one-stage exchange and even
two-stage reimplantation may not warrant eradication 
11. In
some cases additional unconventional steps may be required
for successful treatment.
The aim of this study was to identify an effective treat-
ment algorithm for multidrug resistant Klebsiella-caused
THA or TKA infections.
Methods
All investigations were conducted in conformity with
ethical principles of research, and informed consent for par-
ticipation in the study was obtained.
Since January 2009 to January 2012 we registered and
treated 5 patients with THA or TKA multidrug-resistant
Klebsiella-caused infection. All the patients were primarily
operated in other institutions, and were admitted in our clinic
after the onset of infection symptoms. The hospital records,
operative notes, medications, laboratory reports, microbio-
logical analysis data with antibiograms, and follow-up re-
ports were reviewed. Collected data included patient age,
gender, comorbidities, dates, initial arthroplasty procedure
and subsequent reimplantation procedures, culture results
with antibiograms, type of spacer, antibiotic combination
mixed in the cement, iv and oral antibiotic therapy with the
duration of antibiotic therapy.
There is the established protocol for the diagnosis and
management of infected THA and TKA in our institution. It
starts with preoperative clinical and laboratory evaluation.
Aspiration is routinely performed if a patient was without
antibiotics for at least 14 days prior to aspiration. If the re-
sults a positive for infection a patient is admitted and sched-
uled for surgery. All the patients in this series were initially
planned for two-stage rearthroplasty. Preoperative and post-
operative laboratory evaluation consisted of complete blood
count, urine, biochemical analyzes, C-reactive protein, eryth-
rocyte sedimentation rate, fibrinogen, and in some cases in-
terleukin-6 was obtained. Intravenous (iv) antibiotic therapy
was started after intraoperative cultures and tissue samples
were obtained. In the first stage extraction of THA or TKA
implants and debridement were performed followed by im-
plantation of antibiotic loaded cement spacer (Figure 1).
Fig. 1 – Articulating knee spacer.
In all the cases we used Refobacin
® Revision (Biomet)
bone cement containing a combination of two antibiotics: 1.0
g gentamicin and 1.0 g clindamycin per 40 g of bone cement.
In one case where cultures, in addition to Klebsiela spp. were
positive for Staphyloccocus aureus we intraoperatively
added 2 g of vancomycin per 40 g of bone cement. In all the
cases StageOne (Biomet) knee or hip spacer molds were
used to make articulating spacer molds. After spacer place-
ment no drains were used. Postoperatively, all the patients
were regularly monitored by the infectious disease specialist,
iv and afterwards oral antibiotic regimen was based upon
pathogen sensitivity profile obtained from intraoperative
cultures. Postoperatively, it consisted of combination of iv
antibiotics in two cases, in other two cases iv meropenem 1 g
every 8 h for two weeks, and in one case imipenem/cilastatin
0.5 g every 6 h for two weeks was applied. All patients un-
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parameters during iv antibiotic therapy. Iv antibiotic therapy,
was modified during treatment according to suggestions of
infectious diseases specialist, but in all cases after spacer im-
plantation duration of iv antibiotics lasted less than four
weeks, and oral administration of antibiotics was continued
afterwards. According to preoperative clinical, laboratory
and intraoperative findings, second stage procedure with re-
moval of articulating spaces had two possible outcomes, ei-
ther final reimplantation of definitive prosthesis or three
stage procedure with extraction of previous spacer, addi-
tional debridement and reimplantation of new knee or hip
articulating spacer, and conditionally the 3-stage procedure
with definitive reimplantation.
Klebsiella infections of THA and TKA in this study
were found to be eradicated when at the end of a 12-month
follow-up period after definitive reimplantation, the patients
had no clinical, laboratory nor microbiological parameters
positive for active infection.
Results
During a 3-year period, from January 1, 2009 to De-
cember 31, 2011, we registered and treated 5 patients with
THA or TKA multidrug-resistant Klebsiella-caused infec-
tion. All the patients in the series had microbiologically con-
firmed  Klebsiella prosthetic joint infection. During the
treatment in 3 cases there were other pathogens isolated. All
the patients were female, the mean age at the time of diagno-
sis of infection was 67.4 years (Table 1).
In 3 of the cases we performed 3-stage revision arthro-
plasty (double exchange of articulating cement spacer prior
to reimplantation with definitive prosthesis), and in 2 cases
2-stage revision artheroplasty. The mean length of follow-up
after the reimplantation surgery was 17.1 months (range 2 to
31 months); one patient died two months after the final reim-
plantation procedure. There were 3 infected THA and 2
TKA. The average time after primary arthroplasty and onset
of infection symptoms was 28 days in the cases of THA and
39 days in the TKA cases. All the patients in the series had
microbiologically confirmed Klebsiella  prosthetic joint in-
fection. In 2 of the cases of infected THA and in one case of
infected TKA preoperative aspiration was positive for Kleb-
siella, and in other cases Klebsiella was isolated from intra-
operatively obtained cultures and tissue samples.
During the treatment in 3 cases Klebsiella infection was
additionally complicated by an infection with another bacte-
ria. Two cases of Klebsiella infected total hips treated with
double exchange of articulating spacer were complicated
with additional pathogen, in one case during the first spacer
exchange procedure Pseudomonas aeruginosa was obtained
from intraoperative cultures, and in the other case Staphyloc-
cocus aureus was found postoperatively in aspirations after
first spacer implantation. One case of infected TKA was also
treated with double spacer exchange, Serratia marscescens
was isolated from knee aspirations after the first spacer ex-
change procedure. Adjustments in antibiotic therapy in these
cases were made according to the resistance of Klebsiella
and concomitant bacteria by an infectious diseases specialist.
Table 1
Patients characteristic and procedures
Patients characteris-
tics (age, gender, Dg,
Co)
Primary ar-
throplasty
Infecting
bacteria
Secondary con-
comitant infecting
organism
First spacer
procedure and
duration
Second spacer
procedure type
and duration
Second/third stage
reimplantation
71 f;
Dg: Osteoarthritis,
Co: DM, urinary tract
infection, hyperten-
sion
Cemented
THA
Klebsiella
spp.
Pseudomonas
aeruginosa (iso-
lated in cultures
from first spacer
implantation)
Articulating
hip spacer for
12 weeks
Articulating hip
spacer for 12
weeks
Eradicated, reim-
plantation-
cemented THA
72  f,
Dg:  Rheumatoid ar-
thritis; Co: DM, uri-
nary tract infection
Cemented
THA
Klebsiella
spp.
Staphylococcus
aureus (isolated
from cultures ob-
tained from aspi-
rations after first
spacer implanta-
tion)
Articulating
hip spacer for
12 weeks
Articulating hip
spacer (Refo-
bacin cement
with addition of
vanco-mycin)
for 12 months
Eradicated, reim-
plantation-hybrid
THA
72 f;
Dg: Femoral neck
fracture; Co: hyper-
tension
Cementless
THA
Klebsiella
pneumoniae
Articulating
hip spacer for
8 weeks
None Eradicated, reim-
plantation-
cemented THA,
patient died two
months after final
reimplantation
59 f;
Dg: Osteoarthritis;
Without Co
Bilateral
simultane-
ous TKA
(right knee
got infected
Klebsiella
pneumoniae
Serratia marsces-
cens (isolated in
cultures obtained
during first spacer
implantation)
Articulating
knee spacer
for 8 weeks
Articula-ting
knee spacer
(Refoba-cin
cement)
3months
Eradicated reim-
planted, cemented
LCCK  prosthesis
62 f;
Dg; Rheumatoid ar-
thritis; Co: DM, hy-
pertension
Cemented
TKA
Klebsiella
spp.
Articulating
knee spacer
for 6 months
None Eradicated, reim-
planted cemented
rotation hinge
knee
Dg – primary diagnosis; Co – comorbidity; f – female; DM – diabetes mellitus; THA – total hip arthroplasty; TKA – total knee arthroplasty; LCCK – legacy
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One patient in the series with Klebsiella infected THA,
72 years old, was admitted to our hospital with evident signs
of sepsis, severe anaemia and hepatorenal failure. This pa-
tient had cementless THA, at another institution, after femo-
ral neck fracture, 5 weeks prior to admission in our hospital.
Prior to sepsis development the patient was treated for two
weeks with oral antibiotics at another outpatient clinic and
was referred to our hospital when clinical and laboratory
findings indicated sever deterioration. Besides obesity and
high blood pressure before the primary arthroplasty the pa-
tient had no other comorbidities. This patient underwent 2-
stage revision surgery, after first stage procedure and articu-
lating spacer implantation there were significant positive im-
provements in the patient status. Hepatorenal failure per-
sisted and required regular consults with nephrology and in-
fectious diseases specialists. Eleven weeks after spacer im-
plantation and subsidence of infection signs second stage
procedure, cemented THA was perfomed. Initially early
postoperatively patient was stable and recovering without
complications. But one month after reimplantation cardiac
and renal insufficiency developed, and the patient died 8
weeks after the reimplantation procedure. Considering reim-
plantation THA, at the time of death the patient was clini-
cally, laboratory and microbiologically infection free.
One patient in the series, 59 years old, had bilateral si-
multaneous TKA, during primary arthroplasty procedure
right knee was done first, and there was Klebsiella pneumo-
niae infection of the right TKA, the left knee was infection
free. The onset of infection signs was 6 weeks after primary
arthroplasty. This patient was treated with double spacer ex-
change. The first spacer was removed after 8 weeks, and the
second one after 3 months. Serratia marscescens was iso-
lated from knee aspirations after the first spacer exchange
procedure. Antibiotic therapy was altered according to anti-
biograms by an infectious disease specialist.
In four of the cases end-stage procedures were per-
formed as cemented total hip or knee arthroplasty, Refo-
bacin
® Revision (Biomet) bone cement was used in all the
cases. In one case a hybrid total hip was definitive implant.
All the patients were allowed immediate full weight
bearing. We did not note spacer fractures in any of the cases.
In one case of Klebsiella THA infection after first stage ex-
change 4 weeks postoperatively hip spacer dislocation was
noted (Figure 2).
The average time between removal of primary implants
and definitive reimplantation was 6.8 months (range 2–15
months).
The initial Klebsiella infection was eradicated in all the
patients, at the end follow-up after definitive reimplantation,
patients had no clinical, laboratory or microbiological pa-
rameters positive for active infection. Clinically, at the last
follow-up, except for the patient who died, in both cases of
revision TKA knee, society functional score
 12 improved
from 30 to 90, and in cases of revision THA, Harris hip
score 
13 improved from 57.15 to 89.7.
We have noted the effects of articulating spacer cement
abrasion phenomena (Figure 3.) and in each case thorough
debridement and copious irrigation was perfomed during
each step of the treatment.
Fig. 2 – Dislocated hip spacer.
Fig. 3 – Removed articulating hip spacer – abrasions.
Discussion
The purpose of this study was to identify an algorithm of
treatment of multidrug-resistant Klebsiella-caused THA/TKA
infections.  Klebsiella infections of TKA/THA are relatively
rare 
7–9, but can be very difficult to treat and sometimes can
lead to sepsis, multiorgan failure and ultimately have fatal out-
come.
There are few factors that additionally complicate
treatment. Klebsiella infections of TKA/THAs can be com-
plicated by an additional bacterial infection. Polymicrobial
arthroplasty infections were seen in 6 of 10 knee arthroplasty
patients; these infections involved a mixture of Gram-
positive and Gram-negative species, including Staphylococ-
cus aureus, Staphylococcus epidermidis, Streptococcus spe-
cies,  Escherichia coli, and Enterobacter cloacae 
7, 14–20. In
our series in three cases Klebsiella arthroplasty infection was
additionally complicated by an infection with another bacte-
ria (Staphyloccocus aureus, Pseudomonas aeruginosa and
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In addition to the multiresistant ability, Klebsiella
pneumoniae has several adhesive factors, such as type 1 and
type 3 pili, which help bacteria to adhere to abiotic or bio-
logical surfaces. The adherence of Klebsiella pneumoniae to
cardiac valve prostheses, catheters of urinary tracts, intestinal
cells, and bladder epithelial cells has been previously re-
ported 
21.
Two-stage treatment is currently the most common ap-
proach for management of an infected joint prosthesis, static
antibiotic-impregnated cement spacers have traditionally been
used, increasingly, however, mobile or articulating spacers are
being utilized 
22–24. Although comparisons in the literature of
static and articulating spacers have shown average eradication
rates of approximately 90% and 92%, respectively 
25, articu-
lating spacers have some potential advantages, including more
effective maintenance of the joint space and prevention of soft
tissue contracture, facilitation of local antibiotic delivery, early
mobilization, full or in some cases limited weight bearing, and
possible reduction in bone loss.
In all cases we used antibiotic-loaded cement articulat-
ing hip and knee spacers. In our series of Klebsiella infected
TKA/THA simplex two stage revision was not always suffi-
cient option, and in some cases repetition of articulating an-
tibiotic cement spacer prior to final reathroplasty was re-
quired for eradication of infection.
We used the term 3-stage reimplantation for the proce-
dures of repetition of antibiotic cement spacer prior to reim-
plantation of definitive prosthesis. In the literature generally
accepted understanding of 2-stage reimplantation concept, as
it was firstly described by Insall et al. 
26 and further pro-
moted by other authors 
14, 17, 27, points to the procedures
where the stage one is the operation with removal of infected
implants and application of cement spacer, after a certain pe-
riod of time followed by the stage two, spacer removal and
definitive prosthesis implantation. Some authors consider as
2-stage reimplantation procedures even cases where two ce-
ment spacers exchanges occur before definitive rearthro-
plasty 
7. It could be that in situations where spacer elution
time has subsided, but infection signs are still present and
there are clear indications for one more spacer repetition, a
more appropriate term is 3-stage reimplantation. This slight
change in arthroplasty terminology could contribute to better
recognition and follow-up of persistent periprosthetic joints
infections caused by MDR bacteria treated by double cement
spacer exchange.
Fink et al. 
28 noted that articulating spacers used in 2-
stage revision surgery of infected prostheses have the poten-
tial to abrade and subsequently induce third-body wear of the
new prosthesis. Given the presence of abrasion debris, they
recommend total synovectomy and extensive lavage during
the second-stage reimplantation surgery to minimize the
number of abraded particles and any retained bacteria.
Spacer fractures were reported 
29, 30 but we had no
fractured cemented spacer in the series.
Our study has some limitations. The major deficiencies
are a small number of patients, and its retrospective design.
Larger series and prospective research may be needed to
provide adequate predictions for the appropriate treatment
modality. The small number of patients, and heterogeneity of
the series prevent us from making a definitive recommenda-
tion of which primary treatment is required for eradication of
infection and restitution of function.
Conclusion
In our limited experience with multidrug-resistant Kleb-
siella total knee arthroplasty and total hip arthroplasty infec-
tions, we consider that 2-stage and 3-stage revisions (double
articulating cement spacer exchange prior to definitive reim-
plantation) are the most effective treatment options.
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